NDC 50228-462
Pregabalin Extended Release
Pregabalin
Pregabalin Extended Release is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Sciegen Pharmaceuticals, Inc.. The primary component is Pregabalin.
| Product ID | 50228-462_e90bfe09-9adb-03c0-e053-2a95a90a061e |
| NDC | 50228-462 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pregabalin Extended Release |
| Generic Name | Pregabalin |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-09-14 |
| Marketing Category | ANDA / |
| Application Number | ANDA215675 |
| Labeler Name | ScieGen Pharmaceuticals, INC. |
| Substance Name | PREGABALIN |
| Active Ingredient Strength | 83 mg/1 |
| DEA Schedule | CV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |